Park Avenue Securities’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,384
Closed -$451K 1424
2024
Q1
$451K Buy
1,384
+160
+13% +$39.3K 0.01% 1007
2023
Q4
$233K Buy
+1,224
New +$231K ﹤0.01% 1224
2023
Q1
Sell
-1,170
Closed -$241K 1199
2022
Q4
$241K Buy
1,170
+98
+9% +$24.8K ﹤0.01% 1064
2022
Q3
$298K Sell
1,072
-93
-8% -$23.6K 0.01% 911
2022
Q2
$223K Buy
+1,165
New +$206K ﹤0.01% 1032

Other funds holding SWAV

Park Avenue Securities's SWAV Position: Q2 2024 in Review

Park Avenue Securities sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 1,384 shares — an estimated $451K sold.

Park Avenue Securities first reported a position in SWAV in Q2 2022 and held it in 5 quarters. The position peaked at $451K in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Park Avenue Securities reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Park Avenue Securities sold 1,384 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $451K.
  • Park Avenue Securities first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • Park Avenue Securities's Shockwave Medical, Inc. Common Stock position peaked at $451K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Park Avenue Securities's 13F filing for Q2 2024, filed 9 Jul 2024.